Healthcare    

Fresenius Portfolio of 10

 Nationwide

Asking Price

$29,500,000

Cap Rate

5.48%

Icons_NN-Icon

Expenses

NN Lease Structure

Icon_LocationPin-01

Top Tier Locations

Strong Demographics

Icons_Lease-Icon

Base Lease Term

10 Years

Icons_Growth

Rent Growth

Annual Increases

Icons_BuildSize-SqFt-Icon

Total Square Feet

76,407 SF

Icon_guarantee_shield-1

Strong Tenant

S&P: BBB-

For more details on this exclusive listing

By submitting the form, you agree to the terms and conditions of our Confidential Disclaimer.

INVESTMENT HIGHLIGHTS

  • Geographic Diversification – Unprecedented access to a geographic mix of strong markets with a single credit and user profile 
  • Top Tier Locations – Average five-mile radius includes a population of 111,847 earning an average household income of $84,048.
  • No Early Termination or Kick-Out Clause – All leases are free from early termination options or early kick-out clauses during the initial and any exercised option terms
  • Leading Operator | Fresenius, 4,116 Clinics, 344,000 Patients
  • Investment-Grade Credit | Fresenius, $19.55B revenue, S&P: BBB-
  • Growing Industry | 562,000 ESRD Patients

 

  • Insulated from Macroeconomic Changes | +/-90% of Fresenius' Patients Covered Under Government Program
  • Long-Term Leases – All leases in the Portfolio have more than ten (10) years of initial lease term remaining with three (3), five (5) year renewal options. 
  • Passive Expense Structure – Minimal responsibilities for repair, replacement or maintenance of roof, structure, and HVAC in excess of $3,500 annually. 
  • Rent Growth – All leases provides for annual rental increases throughout the initial and option terms in an amount tied to an index (CPI). 
  • Below Replacement Cost – Each lease was originally a sale-leaseback, rent was not set as a function of building cost and as such each rent and price per square foot are well below replacement cost and prevailing market rates in each market. 

Exclusively Listed By

Scott Briggs

Senior Vice President
  sabriggs@northmarq.com      918.794.9787

Sarah Martin

Lead Marketing & Operations Analyst
  smartin@northmarq.com   

David Read

Investment Analyst
  dread@northmarq.com   

Nathanael Berwaldt

Investment Analyst
  nberwaldt@northmarq.com   

In Association With

Melissa McKenzie

MI Lic. #6502387293

Jeff McKinney

MS Lic. #15504

John Rotunno

NY Lic. #10491208850

Jason Long

TN Lic. #351553

Brian David Corriston

TX Lic. #516241

BJ Feller

IN Lic. #RB14036515

Northmarq

6120 S Yale Ave, Suite 300
Tulsa, OK 74136


northmarq.com